Levamisole in the modulation of the immune response: the current experimental and clinical state.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D006801:Humans; D006968:Hypersensitivity, Delayed; D007109:Immunity; D007700:Kinetics; D007978:Levamisole / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology; D008830:Microbodies / Q000187:drug effects / Q000201:enzymology; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy
D007978:Levamisole; D000251:Adenosine Triphosphatases